Insys says it may be forced to file for bankruptcy due to litigation cash crunch
May 10 (Reuters) - Insys Therapeutics Inc said on Friday that a cash crunch resulting from legal costs related to a U.S. Justice Department probe into...
May 10 (Reuters) - Insys Therapeutics Inc said on Friday that a cash crunch resulting from legal costs related to a U.S. Justice Department probe into...